75N95024F00001

INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935

Department of Health and Human Services · KS, United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number: 75N95024F00001
Issuing organization: Department of Health and Human Services · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935
Source: usaspending
Source ID: CONT_AWD_75N95024F00001_7529_75N95023D00019_7529

Details

Location: KS, United States

Description

INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935 Awarded to: ALTASCIENCES CLINICAL KANSAS INC Sub-agency: National Institutes of Health Contract type: DELIVERY ORDER

Dates

Publication: 2024/09/12 12:00:00 AM UTC
Closing date: 2027/03/10 12:00:00 AM UTC

Estimated value

$1.7M USD

Classification

Normalized category

Healthcare & Medical

Source: usaspending

Last updated 2026-09-02, 1:08:58 p.m.

Data refreshed every 2 hours